Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celescreen

2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of alternative toxicology testing methods. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Primary Office
  • 96 Bis Boulevard Raspail
  • 75006 Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celescreen’s full profile, request a free trial.

Celescreen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 11-Sep-2014 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Celescreen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Agoranov Accelerator/Incubator 000 0000 000000 0